MedPath

Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.

Not Applicable
Conditions
Carotid Stenosis
Registration Number
NCT02915328
Lead Sponsor
Centro Cardiologico Monzino
Brief Summary

Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The intra and/or postprocedural cerebral embolization remains the most frequent complication.

The type of carotid stent and of cerebral protection are the two most important variables potentially affecting the rate of cerebral microembolization. So far there no consensus on the the best stent and cerebral protection.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

significant, unilateral carotid artery stenosis with soft plaque defined as:

  • symptomatic patients: > 1.3 m/sec peak systolic velocity and > 50% diameter stenosis by Doppler ultrasound and < 60 hounsfield unit by CT angiography
  • asymptomatic patients > 2.5 m/sec peak systolic velocity and > 70% diameter stenosis by Doppler ultrasound and < 60 hounsfield unit by CT angiography
Exclusion Criteria
  • severe cerebral vasculopathy with cognitive impairment
  • contraindication to double antiplatelet treatment
  • controlateral carotid occlusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
number of microembolization signals (MES) detected with transcranial dopplerintraprocedural

different phases of carotid stenting (lesion wiring; predilation; stent crossing of the lesion; stent deployment; stent post dilation; device retrieval/deflation

Secondary Outcome Measures
NameTimeMethod
6 month clinical follow up6 month

all strokes, major and minor strokes, myocardial infarction

Doppler ultrasound assesmentday 2 or day 3, 1 month and 6 month

stent patency and long term restenosis of target carotid artery and target vessel external carotid artery

Clinical successday 2 or day 3 and day 30 complication

all strokes, major and minor strokes, myocardial infarction

Trial Locations

Locations (1)

Centro Cardiologico Monzino, IRCCS

🇮🇹

Milan, MI, Italy

Centro Cardiologico Monzino, IRCCS
🇮🇹Milan, MI, Italy
Piero Montorsi, MD
Contact
0038 0258002
Stefano Galli, MD
Contact
0038 0258002

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.